Interim analysis of the COSA (COVID-19 patients treated with the Seraph(®) 100 Microbind(®) Affinity filter) registry

BACKGROUND: The Seraph(®) 100 Microbind(®) Affinity Blood Filter is a haemoperfusion device that is licensed for the reduction of pathogens, including several viruses, in the blood. It received Emergency Use Authorization for the treatment of severe coronavirus disease 2019 (COVID-19) by the Food an...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, Julius J, Borchina, Dan Nicolae, van't Klooster, Mariet, Bulhan-Soki, Khalida, Okioma, Reuben, Herbst, Larissa, Rodríguez, Diego Sandoval, Premužić, Vedran, Büttner, Stefan, Bader, Birgit, Serednicki, Wojciech, Zasada, Ewa, Schmitz, Michael, Quabach, Ralf A, Hrincheva, Maria, Fühner, Thomas, Kielstein, Jan T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689741/
https://www.ncbi.nlm.nih.gov/pubmed/34875087
http://dx.doi.org/10.1093/ndt/gfab347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689741/
https://www.ncbi.nlm.nih.gov/pubmed/34875087
http://dx.doi.org/10.1093/ndt/gfab347

Ejemplares similares